Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2016 Feb 22;11(2):e0149311.
doi: 10.1371/journal.pone.0149311. eCollection 2016.

Caffeine Intake Is Associated with Urinary Incontinence in Korean Postmenopausal Women: Results from the Korean National Health and Nutrition Examination Survey

Jong Min Baek  1 , Jae Yen Song  2 , Sung Jong Lee  2 , Eun Kyung Park  2 , In Cheul Jeung  2 , Chan Joo Kim  2 , Yong Seok Lee  2
Affiliations
Clinical Trial

Caffeine Intake Is Associated with Urinary Incontinence in Korean Postmenopausal Women: Results from the Korean National Health and Nutrition Examination Survey

Jong Min Baek et al. PLoS One. .

Abstract

Introduction: The objective of this study was to investigate whether caffeine intake is associated with urinary incontinence (UI) and quality of life (QOL) in Korean postmenopausal women.

Materials and methods: We included 4,028 postmenopausal women who had participated in the Korea National Health and Nutrition Examination Survey IV (KNHANES IV). From the KNHANES questionnaire data, we ascertained the UI status of participants, defined as self-reported or medically diagnosed UI, and calculated their total daily caffeine intake through questions regarding the frequency of food consumption. The EuroQoL-5 Dimension (EQ-5D) descriptive system was used to evaluate QOL among the study population.

Results: The mean age of the study population was 63.19±0.25 years. Among the 4,028 women, the prevalence of medically diagnosed UI was 2.6% (n = 151), the prevalence of self-reported UI was 11.9% (n = 483), and the lifetime prevalence of UI was 15.8% (n = 639). In the study population, the presence of UI was not significantly different by age group, but daily caffeine consumption and the percentage of caffeine consumer decreased with age (P<0.001). Higher caffeine intake led to significantly higher prevalence of both medically diagnosed UI (p = 0.012) and self-reported UI (p = 0.040) in the study population. Even after adjusting for factors including age, parity, smoking status, hypertension and diabetes in logistic regression analysis, the positive association between caffeine intake and UI prevalence was observed in both medically diagnosed UI and self-reported UI (P = 0.017) among participants. In a subgroup analysis for EQ-5D (using continuous variables) in which we categorized participants into four groups according to UI presence and caffeine consumption, the EQ-5D scores were lower in the caffeine non-user group with UI than in the caffeine consumer group with or without UI.

Conclusion: In a sample of Korean postmenopausal women, the prevalence of UI increased with higher caffeine consumption. Additionally, QOL was lower in caffeine non-users with UI than in the caffeine consumer groups. However, additional prospective studies are required to identify clear causation between caffeine consumption, UI prevalence and QOL.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Flow chart of participant enrollment.
EQ-5D, EuroQoL-5 dimension.
Fig 2
Fig 2. EQ-5D Subgroup Analysis According to the Presence of Medically-diagnosed UI, Self-reported UI and Caffeine Consumption.
EQ-5D, EuroQoL-5 dimension; UI, urinary incontinence. Sub-group analysis employed mean, standard error, and a 95% confidence interval.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Kocak I, Okyay P, Dundar M, Erol H, Beser E. Female urinary incontinence in the west of Turkey: prevalence, risk factors and impact on quality of life. Eur Urol. 2005; 48: 634–641. 10.1016/j.eururo.2005.04.017 - DOI - PubMed
    1. Wood LN, Anger JT. Urinary incontinence in women. Bmj. 2014; 349: g4531 10.1136/bmj.g4531 - DOI - PubMed
    1. Dooley Y, Kenton K, Cao G, Luke A, Durazo-Arvizu R, Kramer H, et al. Urinary incontinence prevalence: results from the National Health and Nutrition Examination Survey. J Urol. 2008; 179: 656–661. 10.1016/j.juro.2007.09.081 - DOI - PubMed
    1. Nygaard I, Barber MD, Burgio KL, Kenton K, Meikle S, Schaffer J, et al. Prevalence of symptomatic pelvic floor disorders in US women. Jama. 2008; 300: 1311–1316. 10.1001/jama.300.11.1311 - DOI - PMC - PubMed
    1. Matthews CA. Risk factors for urinary, fecal, or double incontinence in women. Curr Opin Obstet Gynecol. 2014; 26: 393–397. 10.1097/gco.0000000000000094 - DOI - PubMed

Publication types